These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7417751)

  • 1. The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis.
    Galasko CS; Samuel AW; Rushton S; Lacey E
    Br J Surg; 1980 Jul; 67(7):493-6. PubMed ID: 7417751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by two diphosphonates of bone lysis in tumor-conditioned media.
    Jung A; Mermillod B; Barras C; Baud M; Courvoisier B
    Cancer Res; 1981 Aug; 41(8):3233-7. PubMed ID: 6454481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits.
    Galasko CS; Rawlins R; Bennett A
    Br J Cancer; 1979 Sep; 40(3):360-4. PubMed ID: 508564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases studied in experimental animals.
    Galasko CS
    Clin Orthop Relat Res; 1981; (155):269-85. PubMed ID: 7014059
    [No Abstract]   [Full Text] [Related]  

  • 5. Flurbiprofen: highly potent inhibitor of prostaglandin synthesis.
    Nozu K
    Biochim Biophys Acta; 1978 Jun; 529(3):493-6. PubMed ID: 96864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins as mediators of bone resorption in renal and breast tumours.
    Greaves M; Ibbotson KJ; Atkins D; Martin TJ
    Clin Sci (Lond); 1980 Mar; 58(3):201-10. PubMed ID: 7363561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some mechanisms of local bone destruction by squamous carcinomas of the head and neck.
    Tsao SW; Burman JF; Easty DM; Easty GC; Carter RL
    Br J Cancer; 1981 Mar; 43(3):392-401. PubMed ID: 7225288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostaglandin action and bone resorption by copper.
    Katz JM; Skinner SJ; Wilson T; Gray DH
    Ann Rheum Dis; 1984 Dec; 43(6):841-6. PubMed ID: 6441529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further observations on mechanisms of bone destruction by squamous carcinomas of the head and neck: the role of host stroma.
    Tsao SW; Burman JF; Pittam MR; Carter RL
    Br J Cancer; 1983 Nov; 48(5):697-704. PubMed ID: 6580033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.
    Powles TJ; Clark SA; Easty DM; Easty GC; Neville AM
    Br J Cancer; 1973 Oct; 28(4):316-21. PubMed ID: 4759939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of thiols and inhibitors of prostaglandin biosynthesis on the carcinogen-induced development of mammary lesions in vitro.
    Mehta RG; Steele V; Kelloff GJ; Moon RC
    Anticancer Res; 1991; 11(2):587-91. PubMed ID: 1905901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diphosphonates in the treatment of bone metastases].
    Jung A; Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin or flurbiprofen treatment of periodontitis in beagles: effect on crevicular fluid arachidonic acid metabolites compared with effect on alveolar bone loss.
    Williams RC; Offenbacher S; Jeffcoat MK; Howell TH; Johnson HG; Hall CM; Wechter WJ; Goldhaber P
    J Periodontal Res; 1988 Mar; 23(2):134-8. PubMed ID: 2967365
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro osteolysis by human breast tumours.
    Easty GC; Dowsett M; Powles TJ; Easty DM; Gazet JC; Neville AM
    Proc R Soc Med; 1977 Mar; 70(3):191-5. PubMed ID: 193116
    [No Abstract]   [Full Text] [Related]  

  • 15. A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone.
    Lau KH; Lee MY; Linkhart TA; Mohan S; Vermeiden J; Liu CC; Baylink DJ
    Biochim Biophys Acta; 1985 May; 840(1):56-68. PubMed ID: 2986710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
    Bennett A; Berstock DA; Carroll MA
    Br J Cancer; 1982 May; 45(5):762-8. PubMed ID: 7082558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
    Luo KW; Ko CH; Yue GG; Gao S; Lee JK; Li G; Fung KP; Leung PC; Evdokiou A; Lau CB
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1025-36. PubMed ID: 25431338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
    Powles TJ; Dowsett M; Easty GC; Easty DM; Neville AM
    Lancet; 1976 Mar; 1(7960):608-10. PubMed ID: 55892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.
    Ohba T; Cole HA; Cates JM; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
    J Bone Miner Res; 2014 Jun; 29(6):1431-45. PubMed ID: 24443409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid.
    Carter CA; Ip MM; Ip C
    Carcinogenesis; 1989 Aug; 10(8):1369-74. PubMed ID: 2502321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.